Publication | Open Access
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
257
Citations
18
References
2021
Year
This tubeless automated insulin delivery system was safe and allowed participants to significantly improve HbA<sub>1c</sub> levels and time in target glucose range with a very low occurrence of hypoglycemia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1